PNC Financial Services Group’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52K Sell
42
-137
-77% -$4.02K ﹤0.01% 4755
2026
Q1
$4.42K Buy
179
+128
+251% +$2.24K ﹤0.01% 4320
2025
Q4
$862 Buy
51
+34
+200% +$598 ﹤0.01% 4729
2025
Q3
$369 Buy
+17
New +$282 ﹤0.01% 4851
2021
Q3
Sell
-1,072
Closed -$7K 4323
2021
Q2
$7K Buy
1,072
+673
+169% +$4.99K ﹤0.01% 3790
2021
Q1
$3K Buy
399
+260
+187% +$2.22K ﹤0.01% 3899
2020
Q4
$1K Hold
139
﹤0.01% 3892
2020
Q3
$1K Hold
139
﹤0.01% 3862
2020
Q2
$1K Buy
+139
New +$690 ﹤0.01% 3843

Other funds holding ETON

PNC Financial Services Group's ETON Position: Q2 2026 in Review

PNC Financial Services Group reduced its Eton Pharmaceutcials (ETON) stake by 77% in Q2 2026, selling an estimated $4.02K and leaving 42 shares worth $1.52K. The position accounts for ﹤0.01% of the portfolio, ranked #4755.

PNC Financial Services Group first reported a position in ETON in Q2 2020 and has held it in 9 quarters since. The position peaked at $7K in Q2 2021. 54 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • PNC Financial Services Group held 42 shares of Eton Pharmaceutcials worth $1.52K as of Q2 2026.
  • PNC Financial Services Group sold 137 Eton Pharmaceutcials shares in Q2 2026, an estimated $4.02K.
  • Eton Pharmaceutcials made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4755 holding.
  • PNC Financial Services Group first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 9 quarters since.
  • PNC Financial Services Group's Eton Pharmaceutcials position peaked at $7K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.